1Marten A, Ziske C, Schottker B, et al.lnteractions between dentritic cells and cytokine-induced killer cells lead to an activation of both populations [J]. Immunol, 2001, 24(6): 502-510.
2Linn Y C, Hui K M.NK-like T cells with cytotolitic specificity against leukemia[J].Leuk Lymphoma, 2003, 44(9): 1457-1462.
3Lopez R D, Waller E K, Lu P H, et al.CD58/LFA-3 and IL-2 provided by activate monocytes are critical in the vitro expansion of CD56+T cells[J]. Caneerlmmunollmmunother, 2001, 49(12): 629-640.
6Aaronson N K, Ahmedzai S, Bergman B, et al.The European Organization for Rearch and Treatment of Cancer QLQ-C30 : a quality- of-life instrument for use in international clinical trail in oncology[J].J Natl Cancer lnst, 1993, 85(5): 356-376.
3Lacouture M E, Maitland M L, Segaert S, et al.A proposed EGFR inhibitor dermatologic adverse eventspecifie grading scale from the MASCC skin toxicity study group[J].Supportive Care in Cancer, 2010, 18(4): 509-522.
4Dindo D, Breitenstein S, Hahnloser D, et al.Kinetics of D-dimer after general surgery[J].Blood Coagul Fibrinolysis, 2009, 20(5): 347-352.
